Source:http://linkedlifedata.com/resource/pubmed/id/17697907
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2007-8-16
|
| pubmed:abstractText |
Inappropriate antibiotic therapy (ie, the selection of an empiric agent without activity against the responsible pathogen) of secondary peritonitis may result in poor patient outcomes. The selection of an appropriate agent can be challenging because of the emerging resistance of target organisms to commonly prescribed antibiotics.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0149-2918
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
29
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
889-99
|
| pubmed:meshHeading |
pubmed-meshheading:17697907-Anti-Bacterial Agents,
pubmed-meshheading:17697907-Bacteria, Aerobic,
pubmed-meshheading:17697907-Bacterial Infections,
pubmed-meshheading:17697907-Critical Illness,
pubmed-meshheading:17697907-Drug Resistance, Bacterial,
pubmed-meshheading:17697907-Humans,
pubmed-meshheading:17697907-Microbial Sensitivity Tests,
pubmed-meshheading:17697907-Models, Statistical,
pubmed-meshheading:17697907-Monte Carlo Method,
pubmed-meshheading:17697907-Peritonitis
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
|
| pubmed:affiliation |
Center for Anti-In fective Research and Development, Hartford Hospital, Hartford, CT 06102, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study
|